Enzymatic HbA1c Test Assists in Diagnosing and Monitoring Diabetes
The Atellica CH Enzymatic Hemoglobin A1c assay can be integrated onto chemistry testing platforms.
Read MorePosted by Chaunie Brusie | Jul 7, 2019 | Point-of-Care |
The Atellica CH Enzymatic Hemoglobin A1c assay can be integrated onto chemistry testing platforms.
Read MorePosted by Melissa Mayer | Aug 30, 2018 | Disease States |
This is a companion article to “The Need for Point-of-Care HbA1c Testing for Diabetes.”
Read MorePosted by Steve Halasey | Jul 20, 2018 | Diagnostic Technologies |
Genomic testing underlies the company’s plans to reverse or prevent obesity and type 2 diabetes without medication or surgery.
Read MorePosted by Elaine Sanchez Wilson | Apr 4, 2018 | Clinical Chemistry, Kidney Disease |
The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory associations have announced a collaboration to remove barriers to testing for chronic kidney disease.
Read MorePosted by Steve Halasey | May 5, 2017 | Disease States, Flu & Respiratory Infections, Molecular Diagnostics, Respiratory Disease, Tuberculosis |
Protecting sample stability ensures the utility of the latest generation of TB tests.
Read More